BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 12565836)

  • 1. Critical role of N-terminal N-glycosylation for proper folding of the human formyl peptide receptor.
    Wenzel-Seifert K; Seifert R
    Biochem Biophys Res Commun; 2003 Feb; 301(3):693-8. PubMed ID: 12565836
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High constitutive activity of the human formyl peptide receptor.
    Wenzel-Seifert K; Hurt CM; Seifert R
    J Biol Chem; 1998 Sep; 273(37):24181-9. PubMed ID: 9727041
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quantitative analysis of formyl peptide receptor coupling to g(i)alpha(1), g(i)alpha(2), and g(i)alpha(3).
    Wenzel-Seifert K; Arthur JM; Liu HY; Seifert R
    J Biol Chem; 1999 Nov; 274(47):33259-66. PubMed ID: 10559200
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Defective Gi protein coupling in two formyl peptide receptor mutants associated with localized juvenile periodontitis.
    Seifert R; Wenzel-Seifert K
    J Biol Chem; 2001 Nov; 276(45):42043-9. PubMed ID: 11559706
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of putative sites of interaction between the human formyl peptide receptor and G protein.
    Miettinen HM; Gripentrog JM; Mason MM; Jesaitis AJ
    J Biol Chem; 1999 Sep; 274(39):27934-42. PubMed ID: 10488141
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of the binding site on the formyl peptide receptor using three receptor mutants and analogs of Met-Leu-Phe and Met-Met-Trp-Leu-Leu.
    Mills JS; Miettinen HM; Cummings D; Jesaitis AJ
    J Biol Chem; 2000 Dec; 275(50):39012-7. PubMed ID: 10960471
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mutations of F110 and C126 of the formyl peptide receptor interfere with G-protein coupling and chemotaxis.
    Jones BE; Miettinen HM; Jesaitis AJ; Mills JS
    J Periodontol; 2003 Apr; 74(4):475-84. PubMed ID: 12747452
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The human formyl peptide receptor as model system for constitutively active G-protein-coupled receptors.
    Seifert R; Wenzel-Seifert K
    Life Sci; 2003 Sep; 73(18):2263-80. PubMed ID: 12941430
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Unmasking different constitutive activity of four chemoattractant receptors using Na+ as universal stabilizer of the inactive (R) state.
    Seifert R; Wenzel-Seifert K
    Recept Channels; 2001; 7(5):357-69. PubMed ID: 11697079
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Arrestin binding to the G protein-coupled N-formyl peptide receptor is regulated by the conserved "DRY" sequence.
    Bennett TA; Maestas DC; Prossnitz ER
    J Biol Chem; 2000 Aug; 275(32):24590-4. PubMed ID: 10823817
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Functional differences between human formyl peptide receptor isoforms 26, 98, and G6.
    Wenzel-Seifert K; Seifert R
    Naunyn Schmiedebergs Arch Pharmacol; 2003 May; 367(5):509-15. PubMed ID: 12679864
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Binding of low affinity N-formyl peptide receptors to G protein. Characterization of a novel inactive receptor intermediate.
    Prossnitz ER; Schreiber RE; Bokoch GM; Ye RD
    J Biol Chem; 1995 May; 270(18):10686-94. PubMed ID: 7738006
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The NH2-terminal region of C5aR but not that of FPR is critical for both protein transport and ligand binding.
    Mery L; Boulay F
    J Biol Chem; 1994 Feb; 269(5):3457-63. PubMed ID: 8106386
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Deficient homologous desensitization of formyl peptide receptors stably expressed in undifferentiated HL-60 cells.
    Rane MJ; Prossnitz ER; Arthur JM; Ward RA; McLeish KR
    Biochem Pharmacol; 2000 Jul; 60(2):179-87. PubMed ID: 10825462
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The ligand binding site of the formyl peptide receptor maps in the transmembrane region.
    Miettinen HM; Mills JS; Gripentrog JM; Dratz EA; Granger BL; Jesaitis AJ
    J Immunol; 1997 Oct; 159(8):4045-54. PubMed ID: 9378994
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of a ligand binding site in the human neutrophil formyl peptide receptor using a site-specific fluorescent photoaffinity label and mass spectrometry.
    Mills JS; Miettinen HM; Barnidge D; Vlases MJ; Wimer-Mackin S; Dratz EA; Sunner J; Jesaitis AJ
    J Biol Chem; 1998 Apr; 273(17):10428-35. PubMed ID: 9553101
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regulation of formyl peptide receptor agonist affinity by reconstitution with arrestins and heterotrimeric G proteins.
    Key TA; Bennett TA; Foutz TD; Gurevich VV; Sklar LA; Prossnitz ER
    J Biol Chem; 2001 Dec; 276(52):49204-12. PubMed ID: 11598142
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Partial phosphorylation of the N-formyl peptide receptor inhibits G protein association independent of arrestin binding.
    Bennett TA; Foutz TD; Gurevich VV; Sklar LA; Prossnitz ER
    J Biol Chem; 2001 Dec; 276(52):49195-203. PubMed ID: 11602585
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Extensive contact between Gi2 and N-formyl peptide receptor of human neutrophils: mapping of binding sites using receptor-mimetic peptides.
    Bommakanti RK; Dratz EA; Siemsen DW; Jesaitis AJ
    Biochemistry; 1995 May; 34(20):6720-8. PubMed ID: 7756303
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Physical coupling of N-formyl peptide chemoattractant receptors to G protein is unaffected by desensitization.
    Klotz KN; Jesaitis AJ
    Biochem Pharmacol; 1994 Sep; 48(6):1297-300. PubMed ID: 7945424
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.